Naresh Solanki
Adolescent Medicine · Lake St Louis, MONPI 1225007412
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among adolescent medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Corium, LLC$919
- Ironshore Pharmaceuticals Inc.$822
- Tris Pharma Inc$707
- GSK$514
- Collegium Pharmaceutical, Inc.$284
- plus $2K from 24 others
Across 1 payment — averaging $3581.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$4K
What the payments were for
- Food & beverage$6,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 55 | $1,020 |
| Corium, LLC | 35 | $919 |
| Ironshore Pharmaceuticals Inc. | 31 | $822 |
| Tris Pharma Inc | 30 | $707 |
| GSK | 15 | $514 |
| Collegium Pharmaceutical, Inc. | 10 | $284 |
| Kaleo, Inc. | 15 | $217 |
| Cranial Technologies, Inc | 9 | $192 |
| Sanofi Pasteur Inc. | 8 | $173 |
| Neos Therapeutics, LP | 10 | $171 |
| Merck | 11 | $157 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $148 |
| Rhodes Pharmaceuticals L.p. | 12 | $139 |
| EMD Serono, Inc. | 1 | $106 |
| Seqirus USA Inc | 4 | $106 |
| Noven Pharmaceuticals, Inc. | 1 | $101 |
| Noven Therapeutics, LLC | 5 | $90 |
| Shire North American Group Inc | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Sobi, Inc | 3 | $79 |
| Adlon Therapeutics L.p. | 5 | $66 |
| AstraZeneca | 3 | $65 |
| Vertical Pharmaceuticals, LLC | 4 | $57 |
| Pfizer | 2 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Biomarin Pharmaceutical Inc. | 1 | $25 |
| Alk-abello, Inc | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Teleflex LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$247
- JORNAY PM$237
- BEXSERO$231
- Azstarys$230
- NEFFY$125
- PENMENVY$122
- Dyanavel XR$121
- Quillivant$121
- Quillichew ER$121
- Mavenclad$106
- Jornay PM 20mg capsules (Bottle of 100)$103
- Xelstrym$101
How this compares
$6,458 in reported general payments places this provider in the 95th percentile of 33 adolescent medicine providers in Missouri.
Other adolescent medicine in Lake St Louis
- Paula StuebbenColumbia$3K
- Kelly MeierJoplin$3K
- Laura WeidtColumbia$2K
- Shari SmithJoplin$2K
- Lisa MonseesColumbia$2K
- Holly BondurantColumbia$2K
- Christina RobertsKansas City$1K
- Ariane MaySaint Louis$1K
- Paola LunaKansas City$1K
- Patience OzorKansas City$565
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.